Immunohistochemical analysis of β-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy

Prostate

Volumn 30, Issue 4, 1997, Pages 263-268

  Ranganathan, Sulabha ^a   Salazar, Hernando ^b   Benetatos, Christopher A ^a   Hudes, Gary R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b READING HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

antimicrotubule agents; isotypes; prostate cancer; tubulin

Indexed keywords

BETA TUBULIN; TUMOR MARKER;

ADENOCARCINOMA; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN POLYMERIZATION;

CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; ISOMERISM; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; STAINING AND LABELING; TUBULIN;

EID: 0030895698     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970301)30:4<263::AID-PROS6>3.0.CO;2-M     Document Type: Article

References (27)

1. Sullivan KF: Structure and utilization of tubulin isotypes. Annu Rev Cell Biol 4:687-716, 1988.
2. Fontalba A, Avila J, Zabala JC: β-tubulin folding is modulated by the isotype-specific carboxy-terminal domain. J Mol Biol 246:628-636, 1995.
3. Cross D, Gustavo F, Dominguez J, Avila J, Maccioni RB: Carboxyl terminal sequences of β-tubulin involved in the interaction of HMW-MAPs. Studies using site-specific antibodies. Mol Cell Biochem 132:81-90, 1994.
4. Hoyle HD, Raff EC: Two Drosophila beta isoforms are not functionally equivalent. J Cell Biol 111:1009-1026, 1990.
5. Hall JL, Dudley L, Dobner PR, Lewis A, Cowan NJ: Identification of two human β-tubulin isotypes. Mol Cell Biol 3:854-862, 1983.
6. Little M, Luduena RF: Structural differences between brain β1- and β-2 tubulins: Implications for microtubule assembly and colchicine binding. EMBO J 4:51-56, 1985.
7. Villasante A, Wang D, Dobner P, Dolph P, Lewis SA, Cowan NJ: Six mouse α-tubulin mRNAs encode five distinct isotypes: Testis-specific expression of two sister genes. Mol Cell Biol 6:2409-2419, 1986.
8. Sullivan KF, Cleveland DW: Identification of conserved isotype-defining variable region sequences for four vertebrate β tubulin polypeptide classes. Cell Biol 83:4327-4331, 1986.
9. Lopata MA, Cleveland DW: In vivo microtubules are copolymers of available β-tubulin isotypes: Localization of each of six vertebrate β-tubulin isotypes using polyclonal antibodies elicited by synthetic peptide antigens. J Cell Biol 105:1707-1720, 1987.
10. Lewis SA, Cowan NJ: Complex regulation and functional versatility of mammalian α- and β-tubulin isotypes during the differentiation of testis and muscle cells. J Cell Biol 106:2023-2033, 1988.
11. Hudes GR, Greenberg R, Krigel RL, Fox S, Scher R, Litwin S, Watts P, Speicher L, Tew K, Comis R: Phase II study of estramustine and vinblastine, two microtubule inhibitors in hormone-refractory prostate cancer. J Clin Oncol 10:1754-1761, 1992.
12. Pienta KJ, Redman B, Hussain M, Cummings G, Esper PS, Appel C, Flaherty LE: Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. J Clin Oncol 12:2005-2012, 1994.
13. Hudes GR, Nathan FE, Khater C, Greenberg R, Gomella L, Stern C, McAleer C: Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. Semin Oncol 22:41-45, 1995.
14. Lee JC, Harrison D, Timasheff SN: Interaction of vinblastine with calf brain microtubule protein. J Biol Chem 250:9276-9282, 1975.
15. Rao S, Horwitz SB, Ringel I: Direct photoaffinity labeling of tubulin with taxol. J Natl Cancer Inst 84:785-788, 1992.
16. Dahllof B, Billstrom A, Cabral F, Hartley-Asp B: Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res 53:4573-4581, 1993.
17. Speicher LA, Laing N, Barone LR, Robbins JD, Seamon KB, Tew KD: Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells. Mol Pharmacol 46:866-872, 1994.
18. Stearns ME, Tew KD: Estramustine binds to MAP-2 to inhibit microtubule assembly in vitro. J Cell Sci 89:331-342, 1988.
19. Banerjee A, Roach MC, Trcka P, Luduena RF: Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of β-tubulin. J Biol Chem 265:1794-1799, 1990.
20. Banerjee A, Luduena RF: Distinct colchicine binding kinetics of bovine tubulin lacking the type III isotype of β-tubulin. J Biol Chem 266:1689-1691, 1991.
21. III isotypes enhances taxol induced microtubule assembly. Cell Struct Funct 18:173-182, 1993.
22. Panda D, Miller HP, Banerjee A, Luduena RF, Wilson L: Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc Natl Acad Sci USA 91:11358-11362, 1994.
23. Banerjee A, Roach MC, Wall KA, Lopata MA, Cleveland DW, Luduena R: A monoclonal antibody against the type II isotype of β-tubulin. J Biol Chem 263:3029-3034, 1988.
24. Banerjee A, Roach MC, Trcka P, Luduena R: Preparation of a monoclonal antibody specific for the class IV isotype of β-tubulin. J Biol Chem 267:5625-5630, 1992.
25. Falconer MM, Echeverri CJ, Brown DL: Differential sorting of beta tubulin isotypes into colchicine-stable microtubules during neuronal and muscle differentiation of embryonal carcinoma cells. Cell Motil Cytoskel 21:313-325, 1992.
26. Lobert S, Frankfurter A, Correia JJ: Binding of vinblastine to phosphocellulose-purified and αβ-class III tubulin: The role of nucleotides and β-tubulin isotypes. Biochemistry 34:8050-8060, 1995.
27. Hudes GR: Estramustine-based chemotherapy. Semin Urol Oncol 15:13-19, 1997.